Abstract
Background: Hemostatic agents (HAs) are used to achieve hemostasis and prevent postoperative complications in multiple surgeries, but the role of HAs is ambiguous during partial nephrectomy (PN), so this study aimed to assess the role of HAs in PN. Methods: PubMed, Embase, CENTRAL and ClinicalTrials.gov were searched for randomized controlled trials and cohort studies regarding the comparison of HA use alone and standard suturing during PN on January 17, 2020. RevMan 5.3 was used to conduct meta-analysis. Sensitivity analyses and subgroup analyses were performed based on surgical procedures and HA types. Results: Six studies involving 1,066 patients were included. The quality of studies was moderate to high. There were significant reductions in warm ischemia time (mean difference [MD] = −6.30 min, 95% confidence interval [CI] −7.70 to −4.90, p < 0.00001), operative time (MD = −19.81 min, 95% CI −27.54 to −12.08, p < 0.00001), and estimated blood loss (MD = −108.62 mL, 95% CI −177.27 to −39.9, p = 0.002) in the HA group, and HA use alone did not increase postoperative complications. The results were similar in the subgroup analyses and sensitivity analyses. Conclusion: HA may be an effective and safe surgical material in PN, which can improve postoperative outcomes. High-quality and randomly designed studies are needed to validate the applicability.
References
1.
Ljungberg
B
, Albiges
L
, Abu-Ghanem
Y
, Bensalah
K
, Dabestani
S
, Fernández-Pello
S
, European association of urology guidelines on renal cell carcinoma: the 2019 update
. Eur Urol
. 2019
;75
(5
):799
–810
. .2.
Siemer
S
, Lahme
S
, Altziebler
S
, Machtens
S
, Strohmaier
W
, Wechsel
HW
, Efficacy and safety of tachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study
. Eur Urol
. 2007
;52
(4
):1156
–63
. .3.
Ramani
AP
, Desai
MM
, Steinberg
AP
, Ng
CS
, Abreu
SC
, Kaouk
JH
, Complications of laparoscopic partial nephrectomy in 200 cases
. J Urol
. 2005
;173
(1
):42
–7
. .4.
Tonyali
S
, Koni
A
, Yazici
S
, Bilen
CY
. The safety and efficacy of adjuvant hemostatic agents during laparoscopic nephron-sparing surgery: comparison of tachosil and floseal versus no hemostatic agents
. Urol J
. 2017
;15
(1
):21
–5
. .5.
Dalpiaz
O
, Neururer
R
, Bartsch
G
, Peschel
R
. Haemostatic sealants in nephron-sparing surgery: what surgeons need to know
. BJU Int
. 2008
;102
(11
):1502
–8
. .6.
Pacheco
M
, Barros
AA
, Aroso
IM
, Autorino
R
, Lima
E
, Silva
JM
, Use of hemostatic agents for surgical bleeding in laparoscopic partial nephrectomy: biomaterials perspective
. J Biomed Mater Res B Appl Biomater
. 2020
;108
(8
):3099
–123
.7.
Pruthi
RS
, Chun
J
, Richman
M
. The use of a fibrin tissue sealant during laparoscopic partial nephrectomy
. BJU Int
. 2004
;93
(6
):813
–7
. .8.
Johnston
WK
3rd, Montgomery
JS
, Seifman
BD
, Hollenbeck
BK
, Wolf
JS
Jr. Fibrin glue v sutured bolster: lessons learned during 100 laparoscopic partial nephrectomies
. J Urol
. 2005
;174
(1
):47
–52
. .9.
Aubourg
R
, Putzolu
J
, Bouche
S
, Galmiche
H
, Denis
C
, d’Andon
A
, Surgical hemostatic agents: assessment of drugs and medical devices
. J Visc Surg
. 2011
;148
(6
):e405
–8
. .10.
Takagi
T
, Kondo
T
, Omae
K
, Iizuka
J
, Kobayashi
H
, Yoshida
K
, Assessment of surgical outcomes of the non-renorrhaphy technique in open partial nephrectomy for ≥T1b renal tumors
. Urology
. 2015
;86
(3
):529
–33
. .11.
Moher
D
, Shamseer
L
, Shamseer
L
, Clarke
M
, Ghersi
D
, Liberati
A
, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
. Syst Rev
. 2015
;4
(1
):1
. .12.
Higgins
JPT
, Green
S
. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [Internet]
. 2020
[cited 2020 Jan 10]. Available from: http://handbook-5-1.cochrane.org/.13.
Stang
A
. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
. Eur J Epidemiol
. 2010
;25
(9
):603
–5
. .14.
Mir
MC
, Derweesh
I
, Porpiglia
F
, Zargar
H
, Mottrie
A
, Autorino
R
. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies
. Eur Urolo
. 2017
;71
(4
):606
–17
. .15.
Wan
X
, Wang
W
, Liu
J
, Tong
T
. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
. BMC Med Res Methodol
. 2014
;14
:135
. .16.
Hidas
G
, Kastin
A
, Mullerad
M
, Shental
J
, Moskovitz
B
, Nativ
O
. Sutureless nephron-sparing surgery: use of albumin glutaraldehyde tissue adhesive (BioGlue)
. Urology
. 2006
;67
(4
):697
–700
. .17.
Bahouth
Z
, Moskovitz
B
, Halachmi
S
, Nativ
O
. Bovine serum albumin-glutaraldehyde (BioGlue®) tissue adhesive versus standard renorrhaphy following renal mass enucleation: a retrospective comparison
. Ther Adv Urol
. 2017
;9
(3–4
):67
–72
.18.
Avitan
O
, Gorenberg
M
, Sabo
E
, Bahouth
Z
, Shprits
S
, Halachmi
S
, The use of tissue adhesive for tumor bed closure during partial nephrectomy is associated with reduced devascularized functional volume loss
. Curr Urol
. 2019
;13
(2
):82
–6
. .19.
Tiscione
D
, Cai
T
, Luciani
LG
, Puglisi
M
, Mattevi
D
, Nesi
G
, Sutureless laparoscopic partial nephrectomy using fibrin gel reduces ischemia time while preserving renal function
. Arch Ital Urol Androl
. 2019
;91
(1
):30
–4
. .20.
Lin
Y
, Liao
B
, Lai
S
, Huang
J
, Du
L
, Wang
K
, The application of barbed suture during the partial nephrectomy may modify perioperative results: a systematic review and meta-analysis
. BMC Urol
. 2019
;19
(1
):5
. .21.
Lane
BR
, Demirjian
S
, Derweesh
IH
, Takagi
T
, Zhang
Z
, Velet
L
, Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate
. Eur Urol
. 2015
;68
(6
):996
–1003
. .22.
Hidas
G
, Lupinsky
L
, Kastin
A
, Moskovitz
B
, Groshar
D
, Nativ
O
. Functional significance of using tissue adhesive substance in nephron-sparing surgery: assessment by quantitative SPECT of 99m Tc-dimercaptosuccinic acid scintigraphy
. Eur Urol
. 2007
;52
(3
):785
–9
. .23.
Wille
AH
, Johannsen
M
, Miller
K
, Deger
S
. Laparoscopic partial nephrectomy using FloSeal for hemostasis: technique and experiences in 102 patients
. Surg Innov
. 2009
;16
(4
):306
–12
. .24.
Breda
A
, Stepanian
SV
, Lam
JS
, Liao
JC
, Gill
IS
, Colombo
JR
, Use of haemostatic agents and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases
. Eur Urol
. 2007
;52
(3
):798
–803
. .25.
Antonelli
A
, Minervini
A
, Mari
A
, Bertolo
R
, Bianchi
G
, Lapini
A
, TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: results from a large multicenter dataset
. Int J Urol
. 2015
;22
(1
):47
–52
. .26.
Peyronnet
B
, Oger
E
, Khene
Z
, Verhoest
G
, Mathieu
R
, Roumiguié
M
, The use of hemostatic agents does not prevent hemorrhagic complications of robotic partial nephrectomy
. World J Urol
. 2015
;33
(11
):1815
–20
. .27.
Huang
L
, Liu
GL
, Kaye
AD
, Liu
H
. Advances in topical hemostatic agent therapies: a comprehensive update
. Adv Ther
. 2020
;37
(10
):4132
–48
. .28.
Minervini
A
, Siena
G
, Tuccio
A
, Lapini
A
, Serni
S
, Carini
M
. Sutureless hemostatic control during laparoscopic NSS for the treatment of small renal masses
. Surg Innov
. 2014
;21
(1
):32
–8
. .29.
Maurice
MJ
, Ramirez
D
, Kara
Ö
, Malkoç
E
, Nelson
RJ
, Caputo
PA
, Omission of hemostatic agents during robotic partial nephrectomy does not increase postoperative bleeding risk
. J Endourol
. 2016
;30
(8
):877
–83
. .30.
Ghani
KR
, Sukumar
S
, Sammon
JD
, Rogers
CG
, Trinh
QD
, Menon
M
. Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the nationwide inpatient sample
. J Urol
. 2014
;191
(4
):907
–12
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
